you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Jun 15, 10:29
1116.45 10.60 (0.96%)
Volume
AVERAGE VOLUME
5-Day
113,523
10-Day
69,879
30-Day
65,737
12,782
  • Prev. Close

    1105.85

  • Open Price

    1124.00

  • Bid Price (Qty.)

    1115.65 (1)

  • Offer Price (Qty.)

    1116.45 (1)

NSE Live

Jun 15, 10:29
1115.60 11.30 (1.02%)
Volume
AVERAGE VOLUME
5-Day
1,159,027
10-Day
746,039
30-Day
1,035,798
217,277
  • Prev. Close

    1104.30

  • Open Price

    1114.25

  • Bid Price (Qty.)

    1115.60 (117)

  • Offer Price (Qty.)

    1116.00 (20)

Strengths (5)
  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge
  • Stock gained more than 20% in one month
  • Strong Momentum: Price above short, medium and long term moving averages
Weaknesses (10)
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Decline in Net Profit with falling Profit Margin (QoQ)
  • Decline in Quarterly Net Profit with falling Profit Margin (YoY)
  • Promoter decreasing their shareholding
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Annual net profit declining for last 2 years
  • Fall in Quarterly Revenue and Net Profit (YoY)
  • Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Opportunities (4)
  • Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
  • Brokers upgraded recommendation or target price in the past three months
  • Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
  • RSI indicating price strength
Threats (3)
  • Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
  • Increasing Trend in Non-Core Income
  • Stocks with high PE (PE > 40)
Note :Financial Information is based on Consolidated numbers.